Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,281 public trials 412 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Recruiting

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

NCT06011954

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Site KR82001 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82012 Suwon, Gyeonggi-do, South Korea
  • Site KR82008 Suwon, Gyeonggi-do, South Korea
  • Site KR82007 Jeollanam-do, South Korea
View all 18 locations
View Trial Details
Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations
  • Kaiser Permanente-Division of Research Pleasanton, California, United States
  • Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
  • Kaiser Permanente-Franklin Denver, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 39 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

NCT07106762

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0167 Gilbert, Arizona, United States
  • Local Institution - 0162 Fullerton, California, United States
  • Palo Alto Center-Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Sutter Health - Sutter Institute for Medical Research Sacramento, California, United States
View all 163 locations
View Trial Details
Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

NCT06919965

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Academic Urology and Urogynecology of Arizona Sun City, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Colorado Clinical Research Lakewood, Colorado, United States
  • Georgia Urology Atlanta, Georgia, United States
View all 110 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

NCT07309445

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 13 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions